Status:
RECRUITING
OCT Angiography in Wet AMD
Lead Sponsor:
Oregon Health and Science University
Conditions:
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Eligibility:
All Genders
50-100 years
Brief Summary
The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. diagnose the presence of new blood vessels in wet age-related macular degenerat...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Groups with wet AMD):
- Adults aged 50 and older with clinical findings of treatment-naïve (never treated) neovascular AMD with active new blood vessel growth confirmed by clinical testing will be considered
- Inclusion Criteria (Group with healthy eyes)
- No evidence of retinal disease
- Refractive error greater than +3.00 diopters or -7.00 diopters (glasses Rx)
- No recent eye surgery in the last 4 months
- No significant cataract to interfere with the quality of the imaging
- Exclusion Criteria (All Groups):
- Inability to give informed consent
- Significant kidney disease
- Blood pressure greater than 180/110
- Previous macular laser treatment
- Inability to maintain stable fixation during OCT imaging
- Visual acuity worse than 20/200
Exclusion
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT02253030
Start Date
September 1 2014
End Date
December 1 2026
Last Update
February 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Casey Eye Institute, Oregon Health & Science University
Portland, Oregon, United States, 97239